Market Performance
Takeda Pharmaceutical Company Limited (NYSE:TAK) reached a new 52-week high of $19.69 during today's trading session.
The Healthcare stock has traded year-to-date and 1.2% over the past week. The previous 52-week high was $19.10.
52 week highNYSE:TAK
Takeda Pharmaceutical Company Limited (TAK) Hits New 52-Week High of $19.69
Takeda Pharmaceutical Company Limited (NYSE:TAK) reached a new 52-week high of $19.69 during today's trading session.
At publication ·
What changed
Takeda Pharmaceutical Company Limited (NYSE:TAK) · 52 week high
- Price at event
- $19.69
- Price change
- 1.23%
- Average volume to event volume
- 2.8M to 2.5M
- 52-week high
- $19.10
- 52-week low
- $12.99
At a glance
Key takeaways
- Takeda Pharmaceutical (TAK) reached a new 52-week high of $19.69, up from the previous high of $19.10.
Company Overview
Takeda Pharmaceutical Company Limited has a market capitalization of $45.4B. The stock's 52-week low was $12.99.
Reaching a 52-week high often signals strong momentum and investor confidence in Takeda Pharmaceutical Company Limited. Stocks at new highs can continue trending higher as breakout buying kicks in, though they also face increased selling pressure from profit-taking. The key question is whether fundamentals support the elevated valuation.
Takeda Pharmaceutical Company Limited currently trades at $19.69, positioning the stock at the 100th percentile of its 52-week range ($12.99 — $19.10). This range context helps investors assess whether the stock is trading near support, resistance, or fair value relative to its recent history.
Related Tools: View TAK Stock Page
Frequently Asked Questions
What is causing TAK's price movement?
Price movements can be driven by earnings, analyst actions, or sector trends. Check the latest on our TAK news page.
What is TAK's 52-week range?
See full price history and interactive charts on our TAK chart page.